Growth Accelerated by Increasing Adoption for The Treatment of Neuromuscular Diseases

Antisense Oligonucleotides Market


 Antisense oligonucleotides are short strands of synthetic nucleic acid used to inhibit gene expression through binding to targeted RNA molecules. They are used for the treatment of diseases like Duchenne muscular dystrophy, Huntington's disease, and Alzheimer's disease. Antisense oligonucleotides can specifically suppress targeted genes that cause infections and chronic conditions. The global antisense oligonucleotides market is estimated to be valued at US$ 2913.5 Mn in 2023 and is expected to exhibit a CAGR of 7.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market key trends:
The increasing adoption of antisense oligonucleotides for the treatment of neuromuscular diseases has accelerated the growth of this market. For example, nusinersen sold under the brand name Spinraza is approved for the treatment of spinal muscular atrophy. It helps in improving motor functions and delaying disease progression in patients. Similarly, therapies using antisense oligonucleotides are also being explored for treating Duchenne muscular dystrophy and myotonic dystrophy. The success of these therapies in clinical trials will further drive the demand for antisense oligonucleotides over the forecast period.

Segment Analysis
The global antisense oligonucleotides market is dominated by therapeutic applications sub segment. Antisense oligonucleotides have immense therapeutic potential to selectively inhibit target genes and are used in treating Huntington's diseases, cancer, cardiovascular diseases, and viral infections. Their high specificity to bind target mRNA makes them a preferred treatment option over small molecule drugs.

Key Takeaways
The Global Antisense Oligonucleotides Market Demand is expected to witness high growth.

Regional analysis: North America is expected to remain the dominant region during the forecast period owing to strong government support for research and development activities in the US. Additionally, growing adoption of advanced healthcare technologies also support the market growth.

Key players operating in the antisense oligonucleotides market are SICK AG, Hitachi Ltd., Honeywell International Inc., Hyundai Elevator Co. Ltd., Nidec MCE, Toshiba Elevators and Building Systems, Thames Valley Controls, and Mitsubishi Electric.

For more insights, Read- https://www.insightprobing.com/antisense-oligonucleotides-market-size-and-share/

Comments

Post a Comment

Popular posts from this blog

The Notchback Market is Estimated To Witness High Growth Owing To Rising Demand From Emerging Economies

Image
  Notchback Market Market Overview: A notchback is a body style of cars characterized by a gently sloped rear window and greenhouse. Notchbacks provide practical interior space with good cargo capacity. They offer balanced interior volume for passengers and cargo along with sleek and stylish exterior design. The body style has advantages like no C-pillar which enhances visibility compared to sedans. Market key trends: The growth of the notchback market is attributed to rising demand from emerging economies like China, India and Brazil. These nations have growing middle-class population and increasing disposable income which is driving vehicle ownership. Moreover, notchback body style is quite popular in these developing markets due to its spacious cabin combined with stylish looks at affordable prices. Leading automakers are launching various notchback models to cater to the surging demand from developing countries, which is fueling the growth of the notchback market size during ...
Read more

The Bladder Liners Market Is Estimated To Witness High Growth Owing To Rising Prevalence Of Urinary Incontinence

Image
  Bladder Liners Market Market Overview: Benzodiazepines are a class of psychoactive drugs belonging to the benzodiazepine family. These drugs are prescribed for various medical conditions such as anxiety disorders, panic disorders, insomnia, seizures, alcohol withdrawal syndrome, muscle spasms, and as an anesthesia aid. Some common examples of benzodiazepines include alprazolam, clonazepam, diazepam, and lorazepam. These drugs work by increasing the action of gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the central nervous system. Due to their calming properties, they are widely used to treat insomnia, anxiety, panic attacks, agitation, seizures, muscle spasms, and alcohol withdrawal. Market Dynamics: The Benzodiazepine Drugs Market is primarily driven by the rising prevalence of anxiety disorders worldwide. As per Anxiety and Depression Association of America, anxiety disorders are the most common mental illness in the U.S., affecting nearly 40 million ...
Read more

Commercial Drones Market is Poised to Register Notable Growth Owing to Expanding Usage Across Varied Industries

Image
  Commercial Drones Market  The commercial drones market has been gaining significant traction over the recent years primarily driven by expanding deployment across various industries including agriculture, infrastructure, disaster management, and transportation among others. Commercial drones offer several advantages including cost-effectiveness, flexibility, precision and real-time monitoring capabilities. Meanwhile, growing popularity of drone delivery services across e-commerce as well as healthcare sectors has further catalyzed the market growth. Drones help in reducing operational costs while effectively meeting the target delivery timelines. Additionally, continuous technological advancements have resulted in miniaturization and development of drones with increased payload capacity and battery life. The Global commercial drones market is estimated to be valued at US$ 22.29 Bn in 2024 and is expected to exhibit a CAGR of 13% over the forecast period 2024 to 2031. Key T...
Read more